Accueil
/ Publications
/ Cas client
/ Operational Due Diligence Integration Planning Laboratory Services Acquisition

Operational Due Diligence and Integration Planning for Laboratory Services Acquisition

A leading global laboratory services provider sought to acquire a competing western European operator to strengthen its market position. To support this strategic acquisition, the client required a comprehensive analysis of the target’s processes, organisational structures and performance metrics to determine the operational capabilities, integration feasibility and synergy capability of the potential acquisition.

FTI Consulting delivered an end-to-end operational due diligence spanning the complete laboratory value chain, technology infrastructure, cybersecurity capabilities and executive integrity, providing the multidisciplinary expertise and KPI-driven insights necessary to underpin valuation, de-risk the transaction and build a robust integration roadmap.

Our Impact:

The client realised a holistic KPI-driven assessment of the target’s location structure, human resources and administrative overheads operations throughout the value chain, highlighting optimisation opportunities and reliable synergy estimates to enable best-practice integration.
By building a joint target operating model, the client was able to showcase reliable synergy estimates to underpin the final offer.
With their operations laid out, the client was able to identify synergies and dyssynergies in the target’s practice, which empowered them to make a decision regarding the transaction.

Our Role:

Our experts benchmarked target operations against the buyer’s existing structures and executed a comprehensive, KPI-led operational due diligence across the complete laboratory value chain, from medical order intake, logistics and lab analytics to billing and administrative operations.
FTI Consulting conducted reputational and integrity due diligence on the top three target executives to surface any historical liabilities and foreseen risks.
The team produced specialised assessments of the target’s technology and cybersecurity infrastructure to design a detailed IT integration roadmap with remediation capital expenditures and a hyper care plan to de-risk post-acquisition integration of technology.
Our subject-matter experts in biology, microbiology and pharmacy served as the main interface for operational and subject-matter questions throughout internal and external due diligence streams.